Haitham Jahrami1,2, Eman Alekri3,4, Ahmed S BaHammam5,6, Ali Alsalman3,4, Nicola Luigi Bragazzi7, Omar Alhaj8, Zahra Saif3. 1. Ministry of Health, P.O. Box 12, Manama, Bahrain. HJahrami@health.gov.bh. 2. College of Medicine and Medical Sciences, Arabian Gulf University, Manama, Bahrain. HJahrami@health.gov.bh. 3. Ministry of Health, P.O. Box 12, Manama, Bahrain. 4. College of Medicine and Medical Sciences, Arabian Gulf University, Manama, Bahrain. 5. Department of Medicine, College of Medicine, Respiratory Medicine/University Sleep Disorders Center, King Saud University, Box 225503, Riyadh, 11324, Saudi Arabia. 6. The Strategic Technologies Program of the National Plan for Sciences and Technology and Innovation in the Kingdom of Saudi Arabia, Riyadh, Saudi Arabia. 7. Laboratory for Industrial and Applied Mathematics (LIAM), Department of Mathematics and Statistics, York University, Toronto, ON, Canada. 8. Department of Nutrition, Faculty of Pharmacy and Medical Sciences, University of Petra, Amman, Jordan.
Abstract
PURPOSE: Few previous studies estimated the association between micronutrient status and sleep quality; no previous work was done in patients with depression compared with healthy controls. METHODS: Using a case-control design, 96 patients with depression were age- and sex-matched with 96 healthy controls. Dietary assessment utilized a standardized questionnaire, and analysis focused comprehensively on 18 micronutrient items. Sleep quality was measured using the Pittsburg Sleep Quality Index (PSQI). Descriptive statistics were used to summarize findings. Logistic regression analysis was used to identify predictors of poor sleep quality. RESULTS: Patients with depression had a significantly lower sleep quality than controls with PSQI scores of 7.3 ± 2.7 and 5.1 ± 2.5, respectively. The prevalence of poor sleep quality in patients with depression was almost double the prevalence of poor sleep quality in the general population. The micronutrient status of vitamin B12 and Mg successfully predicted sleep quality in healthy controls. However, in patients with depression, micronutrient status failed to predict sleep quality. CONCLUSIONS: The current research showed that sleep quality was positively associated with Mg intake, and negatively associated with vitamin B12 in healthy adults. For patients with depression in this study sample, sleep quality was not associated with micronutrient intake status. Further research is needed to determine if intake of micronutrients can improve sleep and/or depressive symptoms in patients with depression.
PURPOSE: Few previous studies estimated the association between micronutrient status and sleep quality; no previous work was done in patients with depression compared with healthy controls. METHODS: Using a case-control design, 96 patients with depression were age- and sex-matched with 96 healthy controls. Dietary assessment utilized a standardized questionnaire, and analysis focused comprehensively on 18 micronutrient items. Sleep quality was measured using the Pittsburg Sleep Quality Index (PSQI). Descriptive statistics were used to summarize findings. Logistic regression analysis was used to identify predictors of poor sleep quality. RESULTS: Patients with depression had a significantly lower sleep quality than controls with PSQI scores of 7.3 ± 2.7 and 5.1 ± 2.5, respectively. The prevalence of poor sleep quality in patients with depression was almost double the prevalence of poor sleep quality in the general population. The micronutrient status of vitamin B12 and Mg successfully predicted sleep quality in healthy controls. However, in patients with depression, micronutrient status failed to predict sleep quality. CONCLUSIONS: The current research showed that sleep quality was positively associated with Mg intake, and negatively associated with vitamin B12 in healthy adults. For patients with depression in this study sample, sleep quality was not associated with micronutrient intake status. Further research is needed to determine if intake of micronutrients can improve sleep and/or depressive symptoms in patients with depression.
Authors: Seithikurippu R Pandi-Perumal; Jaime M Monti; Deepa Burman; Ramanujam Karthikeyan; Ahmed S BaHammam; David Warren Spence; Gregory M Brown; Meera Narashimhan Journal: Psychiatry Res Date: 2020-06-16 Impact factor: 3.222
Authors: Kim Hinkelmann; Steffen Moritz; Johannes Botzenhardt; Christoph Muhtz; Klaus Wiedemann; Michael Kellner; Christian Otte Journal: Psychoneuroendocrinology Date: 2011-09-23 Impact factor: 4.905
Authors: Daniel Freeman; Bryony Sheaves; Guy M Goodwin; Ly-Mee Yu; Alecia Nickless; Paul J Harrison; Richard Emsley; Annemarie I Luik; Russell G Foster; Vanashree Wadekar; Christopher Hinds; Andrew Gumley; Ray Jones; Stafford Lightman; Steve Jones; Richard Bentall; Peter Kinderman; Georgina Rowse; Traolach Brugha; Mark Blagrove; Alice M Gregory; Leanne Fleming; Elaine Walklet; Cris Glazebrook; E Bethan Davies; Chris Hollis; Gillian Haddock; Bev John; Mark Coulson; David Fowler; Katherine Pugh; John Cape; Peter Moseley; Gary Brown; Claire Hughes; Marc Obonsawin; Sian Coker; Edward Watkins; Matthias Schwannauer; Kenneth MacMahon; A Niroshan Siriwardena; Colin A Espie Journal: Lancet Psychiatry Date: 2017-09-06 Impact factor: 27.083
Authors: Wen Chen; Mo'ez Al-Islam E Faris; Nicola Luigi Bragazzi; Haifa M S AlGahtani; Zahra Saif; Ahmed Jahrami; Nitin Shivappa; James R Hebert; Haitham Jahrami Journal: J Inflamm Res Date: 2021-04-15